BRUSSELS (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent ...

A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping ...

Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although ...

The antiseizure drugs levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam, generic) and clobazam (Onfi, Sympazan, generic) can cause a rare but serious drug hypersensitivity reaction that can be ...

Levetiracetam 100mg/mL; grape flavor; dye-free. Swallow tabs whole. Partial onset: ≥16yrs: initially 500mg twice daily. May increase at 2-week intervals in increments of 1g/day; max 3g/day. Myoclonic: ...

A study found that neighboring areas within the pulvinar connect to different brain networks. The findings may help ...

Current medical news and unique business news for anyone who cares about the healthcare industry. UCB fined for off-label use: Belgian drug company UCB must pay more than $34 million in fines after ...